Few consultants or service providers can offer the complete strategy to implementation capabilities of Solem's experienced team, proven commercial launch plan and powerful resource network.
Solem offers clear executable strategies for entering a heterogeneous market place of a multitude of different countries, governments, languages, customs and commercial requirements.
We partner with our clients to identify the optimal path to commercialization whether that outcome suggests partnering, organic development or Solem's integrated partnering alternative.
Solem's network can provide stand-alone or integrated solutions depending upon our client's therapeutic area, functional or geographic requirements.
Our service portfolio is based upon the capabilities of Solem's novel commercial platform. Accordingly, we can efficiently manage any capability a local partner or service provider would offer including:
- Virtual launch team
- Surrogate EU HQ management
- Launch Preparation
- Market Access
- Corporate infrastructure
- Regulatory
- Sales and marketing
- Contract sales organization
- Pharmacovigilance
- Medical Affairs
- Supply chain
- QA/ QP
The current commercial landscape has shifted and outlicensing may not yield the returns it once garnered.
Solem's acquireable integrated corporate plaform offers an innovative way to commercialize in Europe and create value for our partners.
Our measured gated approach to Europe where direct participation and investment in the corporate infrastructure could evolve and align with the growth of the European business or management's desired interaction.
European expansion no longer stops at Western Europe.
Solem can offer our clients and partners a similar level of expertise, local market access and on demand resources as in Western Europe but covering a group of in new and developing markets.
Please click here to see a map of our territories.